Previous 10 | Next 10 |
BOTHELL, Wash., May 07, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replicatio...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ibio (NYSEAMERICAN: IBIO ) stock is soaring higher on Friday after announcing a next-generation vaccine program to treat the novel coronavirus. Source: Shutterstock This new program has it developing IBIO-202...
Gainers: Regional Health Properties (RHE) +124%.SunLink Health Systems (SSY) +66%.Nemaura Medical (NMRD) +60%.Chiasma (CHMA) +48%.Athenex (ATNX) +31%.Caesarstone (CSTE) +30%.Hayward (HAYW) +28%.Altisource Portfolio Solutions (ASPS) +26%.Big 5 Sporting Goods (BGFV) +26%.American...
Esperion Therapeutics (ESPR) -32% on Q1 earnings release.Cocrystal Pharma (COCP) -27% after launches $40M stock offering.SemiLEDs (LEDS) -21%.Mercury Systems (MRCY) -18% on FQ3 earnings release.Adamis Pharmaceuticals (ADMP) -14%.Reed's (REED) -14% after...
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replicatio...
Gainers: Cocrystal Pharma (COCP) +157%.BioLineRx (BLRX) +75%.Reed's (REED) +36%.Neuronetics (STIM) +25%.Shineco (TYHT) +24%.Domtar (UFS) +18%.Arconic (ARNC) +17%.Huttig Building Products (HBP) +15%.Village Bank and Trust Financial (VBFC) +15%.Precipio (PRPO) +13%.Losers: ChemoC...
3 Reddit Penny Stocks to Watch as the Crypto Hype Continues With penny stocks, outside factors can have a large impact on what occurs throughout the market. This could be something as simple as news or even DogeCoin hitting an all-time high. This is referred to as speculation and is the...
Gainers: Cocrystal Pharma (COCP) +97%, BioLineRx (BLRX) +51%, Neuronetics (STIM) +21%, Shineco (TYHT) +20%, Precipio (PRPO) +14%.Losers: ChemoCentryx (CCXI) -38%, Regional Health Properties (RHE) -35%, Brooklyn ImmunoTherapeutics (BTX) -3...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips News that Cocrystal Pharma (NASDAQ: COCP ) has made progress on its Covid-19 antiviral drug candidates and plans to expand development has sent the COCP stock price up more than 40% in Tuesday’s pre-market trad...
BioLineRx (BLRX) +62% on positive top-line results from GENESIS phase 3 trial.Cocrystal Pharma (COCP) +40%.Huttig Building Products, Inc. (HBP) +26% on Q1 results.Vaxart (VXRT) +20% as its oral COVID-19 vaccine shows potential to offer promising solution against variants.Precip...
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human...
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitor Topline data expected in 2024 from Phase 2a influenza A human challen...
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received Pre-Investigational New D...